Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
3 hedge funds and large institutions have $3.93M invested in Putnam BioRevolution ETF in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more capital invested
Capital invested by funds: $3.92M → $3.93M (+$11.1K)
0% more funds holding
Funds holding: 3 → 3 (0)
0.18% less ownership
Funds ownership: 70.18% → 70% (-0.18%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$10.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.9M | – | – | – |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $31K | -$10.1K | -329 | -25% |
|
3
UBS Group
Zurich,
Switzerland
| $374 | – | – | – |
|
SYNB Hedge Fund Activity: Q2 2024 in Review
3 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q2 2024, worth a combined $3.93M — up 0.28% from $3.92M a quarter earlier.
Fund positioning in SYNB was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Royal Bank of Canada, cutting an estimated $10.1K.
- 3 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $3.93M of Putnam BioRevolution ETF stock for Q2 2024, up 0.28% quarter-over-quarter.
- 0 funds opened new Putnam BioRevolution ETF positions in Q2 2024 and 0 closed out.
- The largest Putnam BioRevolution ETF seller in Q2 2024 was Royal Bank of Canada, an estimated $10.1K sold.
Based on aggregated 13F filings for Q2 2024.